Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region

Tumor Biology

Volumn 31, Issue 1, 2010, Pages 33-45

  Birerdinc, Aybike ^a   Nohelty, Elizabeth ^a   Marakhonov, Andrey ^b   Manyam, Ganiraju ^a   Panov, Ivan ^a   Coon, Stephanie ^a   Nikitin, Eugene ^c   Skoblov, Mikhail ^b   Chandhoke, Vikas ^a   Baranova, Ancha ^a,b  

^a GEORGE MASON UNIVERSITY   (United States)

^b RESEARCH CENTRE FOR MEDICAL GENETICS   (Russian Federation)

^c NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

Author keywords

13q14; Chronic lymphocytic leukemia; KCNRG; Multiple myeloma; Potassium channels; Tumor suppressor candidate

Indexed keywords

ISOPROTEIN; MESSENGER RNA; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCN REGULATING PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRAIN HL 60; CELL STRAIN LNCAP; CHROMOSOME 13Q; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE COURSE; EXON; GENE DELETION; GENE EXPRESSION REGULATION; GENE LOCUS; GENE OVEREXPRESSION; GENE SEQUENCE; GENOME ANALYSIS; HAPLOTYPE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOMA; MOLECULAR CLONING; MULTIPLE MYELOMA; MUTATIONAL ANALYSIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 77951091450     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-009-0005-0     Document Type: Article

References (37)

1. Caporaso N, Marti GE, Goldin L. Perspectives on familial chronic lymphocytic leukaemia: genes and the environment. Semin Hematol. 2004;41:201-206
2. Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL. The clinical and epidemiological burden of chronic lymphocytic leukaemia. Eur J Cancer Care (Engl). 2004;13:279-287 (Pubitemid 38834460)
3. Danilov AV, Danilova OV, Klein AK, Huber BT. Molecular pathogenesis of chronic lymphocytic leukaemia. Curr Mol Med. 2006;6:665-675
4. Gale RP, Foon KA. Biology of chronic lymphocytic leukaemia. Semin Hematol. 1987;24:209-229
5. Ougolkov AV, Bone ND, Fernandez-Zapico ME, Kay NE, Billadeau DD. Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukaemia B cells. Blood. 2007;110:735-742
6. Iglesias-Serret D, de Frias M, Santidrian AF, Coll-Mulet L, Cosialls AM, Barragán M, et al. Regulation of the proapoptotic BH3-only protein BIM by glucocorticoids, survival signals and proteasome in chronic lymphocytic leukaemia cells. Leukemia. 2007;21:281-287
7. Bueso-Ramos CE, Ferrajoli A, Medeiros LJ, Keating MJ, Estrov Z. Aberrant morphology, proliferation, and apoptosis of B-cell chronic lymphocytic leukaemia cells. Hematology. 2004;9:279-286
8. Chiorazzi N, Ferrarini M. Evolving view of the in-vivo kinetics of chronic lymphocytic leukaemia B cells. Hematology Am Soc Hematol Educ Program. 2006;273-8:512.
9. Liu Y, Corcoran M, Rasool O, Ivanova G, Ibbotson R, Grandér D, et al. Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukaemia. Oncogene. 1997;15:2463-2473
10. Dohner H, Stilgenbauer S, Dohner K, Bentz M, Lichter P. Chromosome aberrations in B-cell chronic lymphocytic leukaemia: reassessment based on molecular cytogenetic analysis. J Mol Med. 1999;77:266-281
11. Rosenwald A, Ott G, Krumdiek AK, Dreyling MH, Katzenberger T, Kalla J, et al. A biological role for deletions in chromosomal band 13q14 in mantle cell and peripheral t-cell lymphomas? Genes, Chromosomes Cancer. 1999;26:210-214
12. Harrison CJ, Mazzullo H, Cheung KL, Gerrard G, Jalali GR, Mehta A, et al. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results. Br J Haematol. 2003;120:944-952
13. Elnenaei MO, Hamoudi RA, Swansbury J, Gruszka-Westwood AM, Brito-Babapulle V, Matutes E, et al. Delineation of the minimal region of loss at 13q14 in multiple myeloma. Genes Chromosomes Cancer. 2003;36:99-106.
14. Lu W, Takahashi H, Furusato M, Maekawa S, Nakano M, Meng C, et al. Allelotyping analysis at chromosome 13q of high-grade prostatic intraepithelial neoplasia and clinically insignificant and significant prostate cancers. Prostate. 2006;66:405-412
15. Rowntree C, Duke V, Panayiotidis P, Kotsi P, Palmisano GL, Hoffbrand AV, et al. Deletion analysis of chromosome 13q14.3 and characterisation of an alternative splice form of LEU1 in B cell chronic lymphocytic leukaemia. Leukemia. 2002;16:1267-1275
16. Tyybakinoja A, Vilpo J, Knuutila S. High-resolution oligonucleotide array-CGH pinpoints genes involved in cryptic losses in chronic lymphocytic leukaemia. Cytogenet Genome Res. 2007;118:8-12.
17. Kapanadze B, Kashuba V, Baranova A, Rasool O, van Everdink W, Liu Y, et al. A cosmid and cDNA fine physical map of a human chromosome 13q14 region frequently lost in B-cell chronic lymphocytic leukaemia and identification of a new putative tumor suppressor gene, Leu5. FEBS Lett. 1998;426:266-270
18. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukaemia. Proc Natl Acad Sci USA. 2002;99:15524-15529
19. Baranova A, Hammarsund M, Ivanov D, Skoblov M, Sangfelt O, Corcoran M, et al. Distinct organization of the candidate tumor suppressor gene RFP2 in human and mouse: multiple mRNA isoforms in both species-and human-specific antisense transcript RFP2OS. Gene. 2003;321:103-112
20. Wolf S, Mertens D, Schaffner C, Korz C, Korz C, Döhner H, et al. B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions. Hum Mol Genet. 2001;10:1275-1285
21. van Everdink WJ, Baranova A, Lummen C, Tyazhelova T, Looman MW, Ivanov D, et al. RFP2, c13ORF1, and FAM10A4 are the most likely tumor suppressor gene candidates for B-cell chronic lymphocytic leukaemia. Cancer Genet Cytogenet. 2003;146:48-57.
22. Mertens D, Wolf S, Schroeter P, Schaffner C, Döhner H, Stilgenbauer S, et al. Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukaemia. Blood. 2002;99:4116-4121
23. Ivanov DV, Tyazhelova TV, Lemonnier L, Kononenko N, Pestova AA, Nikitin EA, et al. A new human gene KCNRG encoding potassium channel regulating protein is a cancer suppressor gene candidate located in 13q14.3. FEBS Lett. 2003;539:156-160
24. Rybalchenko V, Prevarskaya N, Van Coppenolle F, Legrand G, Lemonnier L, Le Bourhis X, et al. Verapamil inhibits proliferation of LNCaP human prostate cancer cells influencing K+ channel gating. Mol Pharmacol. 2001;59:1376-1387
25. Lewis RS, Cahalan MD. Potassium and calcium channels in lymphocytes. Annu Rev Immunol. 1995;13:623-653
26. Smith GA, Tsui HW, Newell EW, Jiang X, Zhu XP, Tsui FW, et al. Functional up-regulation of HERG K+ channels in neoplastic hematopoietic cells. J Biol Chem. 2002;277:18528-18534
27. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1989.
28. Kim YH, Proust JJ, Buchholz MJ, Chrest FJ, Nordin AA. Expression of the murine homologue of the cell cycle control protein p34cdc2 in T lymphocytes. J Immunol. 1992;149:17-23.
29. Grace MB, McLeland CB, Gagliardi SJ, Smith JM, Jackson WE, Blakely WF. Quantitative RT-PCR assay using simultaneous measurement of four fluorophores for radiation-responsive gene targets. Clin Chem. 2003;49:1467-1475
30. Lerner M, Corcoran M, Cepeda D, Nielsen ML, Zubarev R, Pontén F, et al. The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERAD. Mol Biol Cell. 2007;18:1670-1682
31. Skoblov M, Shakhbazov K, Oshchepkov D, Ivanov D, Guskova A, Ivanov D, et al. Human RFP2 gene promoter: unique structure and unusual strength. Biochem Biophys Res Commun. 2006;342: 859-866
32. Stogios PJ, Downs GS, Jauhal JJ, Nandra SK, Privé GG. Sequence and structural analysis of BTB domain proteins. Genome Biol. 2005;6(10):R82.
33. Raveche ES, Salerno E, Scaglione BJ, Manohar V, Abbasi F, Lin YC, et al. Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood. 2007;109:5079-5086
34. Cho YG, Kim CJ, Song JH, Rhie DJ, Park YK, Kim SY, et al. Genetic and expression analysis of the KCNRG gene in hepatocellular carcinomas. Exp Mol Med. 2006;38:247-255
35. Liu JP, Liu NS, Yuan HY, Guo Q, Lu H, Li YY. Human homologue of SETA binding protein 1 interacts with cathepsin B and participates in TNF-Induced apoptosis in ovarian cancer cells. Mol Cell Biochem. 2006;292:189-195
36. Argenti B, Gallo R, Di Marcotullio L, Ferretti E, Napolitano M, Canterini S, et al. Hedgehog antagonist REN(KCTD11) regulates proliferation and apoptosis of developing granule cell progenitors. J Neurosci. 2005;25:8338-8346
37. Suehara Y, Kondo T, Seki K, Shibata T, Fujii K, Gotoh M, et al. Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics. Clin Cancer Res. 2008;14:1707-1717